276 related articles for article (PubMed ID: 27861759)
21. [Pathogenesis and epidemiology of Barrett esophagus].
Spechler SJ
Chirurg; 1994 Feb; 65(2):84-7. PubMed ID: 8162820
[No Abstract] [Full Text] [Related]
22. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
23. Bax upregulation may provide a rationale for the low incidence of esophageal adenocarcinoma in a Greek cohort of patients with Barrett's esophagus.
Chatzopoulos D; Kyrgidis A; Kountouras J; Zavos C; Molyvas E; Venizelos I
Hepatogastroenterology; 2007; 54(75):705-9. PubMed ID: 17591046
[TBL] [Abstract][Full Text] [Related]
24. Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis.
Loomans-Kropp HA; Chaloux M; Richmond E; Umar A
Cancer Prev Res (Phila); 2021 Feb; 14(2):195-204. PubMed ID: 32998939
[TBL] [Abstract][Full Text] [Related]
25. The continuum of GERD complications.
Fennerty MB
Cleve Clin J Med; 2003 Nov; 70 Suppl 5():S33-50. PubMed ID: 14705380
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and molecular biology of Barrett esophagus.
Casson AG; Williams L; Guernsey DL
Semin Thorac Cardiovasc Surg; 2005; 17(4):284-91. PubMed ID: 16428034
[TBL] [Abstract][Full Text] [Related]
27. Barrett Esophagus: A Review.
Sharma P
JAMA; 2022 Aug; 328(7):663-671. PubMed ID: 35972481
[TBL] [Abstract][Full Text] [Related]
28. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma.
Oberg S; Wenner J; Johansson J; Walther B; Willén R
Ann Surg; 2005 Jul; 242(1):49-54. PubMed ID: 15973101
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.
Hampel H; Abraham NS; El-Serag HB
Ann Intern Med; 2005 Aug; 143(3):199-211. PubMed ID: 16061918
[TBL] [Abstract][Full Text] [Related]
30. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
[TBL] [Abstract][Full Text] [Related]
31. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.
Dong J; Maj C; Tsavachidis S; Ostrom QT; Gharahkhani P; Anderson LA; Wu AH; Ye W; Bernstein L; Borisov O; Schröder J; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; May A; Gerges C; Anders M; Venerito M; Schmidt T; Izbicki JR; Hölscher AH; Schumacher B; Vashist Y; Neuhaus H; Rösch T; Knapp M; Krawitz P; Böhmer A; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Corley DA; Gockel I; Fitzgerald RC; ; Cook MB; Whiteman DC; Vaughan TL; Schumacher J; Thrift AP
Gastroenterology; 2020 Dec; 159(6):2065-2076.e1. PubMed ID: 32918910
[TBL] [Abstract][Full Text] [Related]
32. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction.
Rubenstein JH; Raghunathan T; Doan C; Schneider J; Zhao W; Metko V; Nofz K; Khodadost M; Corley DA
Am J Gastroenterol; 2021 May; 116(5):949-957. PubMed ID: 33852454
[TBL] [Abstract][Full Text] [Related]
33. Screening and surveillance for complications related to gastroesophageal reflux disease.
Spechler SJ
Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
[TBL] [Abstract][Full Text] [Related]
34. The Role of Esophagogastroduodenoscopy Surveillance for Patients with Barrett Esophagus.
Palamara K
Med Clin North Am; 2016 Sep; 100(5):1057-64. PubMed ID: 27542425
[TBL] [Abstract][Full Text] [Related]
35. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.
Dixon JL; Copeland LA; Zeber JE; MacCarthy AA; Reznik SI; Smythe WR; Rascoe PA
Dis Esophagus; 2016 Oct; 29(7):747-751. PubMed ID: 26455587
[TBL] [Abstract][Full Text] [Related]
36. Cystic fibrosis is associated with an increased risk of Barrett's esophagus.
Knotts RM; Solfisburg QS; Keating C; DiMango E; Lightdale CJ; Abrams JA
J Cyst Fibros; 2019 May; 18(3):425-429. PubMed ID: 30473189
[TBL] [Abstract][Full Text] [Related]
37. Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia.
Velanovich V; Hollingsworth J; Suresh P; Ben-Menachem T
Dig Surg; 2002; 19(5):349-53. PubMed ID: 12435904
[TBL] [Abstract][Full Text] [Related]
38. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Pera M
World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
[TBL] [Abstract][Full Text] [Related]
39. Esophageal adenocarcinoma arising in Barrett esophagus.
Zhang HY; Spechler SJ; Souza RF
Cancer Lett; 2009 Mar; 275(2):170-7. PubMed ID: 18703277
[TBL] [Abstract][Full Text] [Related]
40. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.
Thrift AP; Anderson LA; Murray LJ; Cook MB; Shaheen NJ; Rubenstein JH; El-Serag HB; Vaughan TL; Schneider JL; Whiteman DC; Corley DA
Am J Gastroenterol; 2016 Nov; 111(11):1528-1535. PubMed ID: 27575711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
